|
|
|
| The Relationship Between Serum Magnesium Decreased and Coronary Artery Disease Complicated with Diabetes |
| SI Yueqiao, FAN Wenjun, GAO Xiuxin, et al |
| The Affiliated Hospital of Chengde Medical College / Chengde Cardiovascular Institute, Hebei Chengde 067000,China |
|
|
|
|
Abstract Objective: To explore the correlation between serum magnesium levels and coronary artery disease (CAD) complicated with diabetes. Methods: A total of 467 eligible inpatients with suspected CAD from January 2015 to June 2017 in our hospital were consecutively enrolled in the study. All of them were divided into CAD diabetes (n=129), CAD non-diabetes (n=201), non-CAD diabetes (n=33), and non-CAD non-diabetic group (n=104). Clinical data was collected and total coronary artery calcification (CAC) score was calculated. Multivariate logistic regression model was used to analyze the risk factors of CAD complicated with diabetes. Results: Dyslipidemia, pulse pressure≥60mmHg, CAC score>400, EF<50% and serum magnesium≤0.77mmol/L are all risk factors for CAD with diabetes, serum magnesium≤0.77mmol/L being the highest risk. The risk of serum magnesium decreased in CAD with diabetes group was 2.806 times higher than control group (P<0.05). Conclusion: Serum magnesium decreased is an independent risk factor of CAD complicated with diabetes, which can be used as a biomarker of reference for clinical diagnosis.
|
|
|
|
|
|
[1] Patsouras A, Farmaki P, Garmpi A, et al. Screening and risk assessment of coronary artery disease in patients with type 2 diabetes: an updated review[J]. In Vivo, 2019, 33(4):1039~1049.
[2] Larsson SC, Burgess S, Michaelsson K. Serum magnesium levels and risk of coronary artery disease: mendelian randomisation study[J]. BMC Med, 2018, 16(1):68.
[3] Diaz-Tocados JM, Peralta-Ramirez A, Rodrguez-Ortiz ME, et al. Dietary magnesium supplementation prevents and reverses vascular and soft tissue calcifications in uremic rats[J]. Kidney Int, 2017, 92(5):1084~1099.
[4] Chen W, Fitzpatrick J, Monroy-Trujillo JM, et al. Diabetes mellitus modifies the associations of serum magnesium concentration with arterial calcification and stiffness in incident hemodialysis patients[J]. Kidney Int Rep, 2019, 4(6):806~813.
[5] Ter Braake AD, Tinnemans PT, Shanahan CM, et al. Magnesium prevents vascular calcification in vitro by inhibition of hydroxyapatite crystal formation[J]. Sci Rep, 2018, 8(1):2069.
[6] Joris PJ, Plat J, Bakker SJ, et al. Long-term magnesium supplementation improves arterial stiffness in overweight and obese adults: results of a randomized, double-blind, placebo-controlled intervention trial[J]. Am Clin Nutr, 2016, 103(5):1260~1266.
[7] Wannamethee SG, Papacosta O, Lennon L, et al. Serum magnesium and risk of incident heart failure in older men: The British Regional Heart Study[J]. Eur J Epidemiol, 2018, 33(9):873~882.
[8] RodrIguez-Ortiz ME, Gómez-Delgado F, Arenas de Larriva AP, et al. Serum magnesium is associated with carotid atherosclerosis in patients with high cardiovascular risk (CORDIOPREV Study)[J]. Sci Rep, 2019, 9(1):8013.
[9] Verma H, Garg R. Effect of magnesium supplementation on type 2 diabetes associated cardiovascular risk factors: a systematic review and meta-analysis[J].Hum Nutr Diet, 2017, 30(5):621~633.
[10] Han H, Fang X, Wei X, et al. Dose-response relationship between dietary magnesium intake, serum magnesium concentration and risk of hypertension: a systematic review and meta-analysis of prospective cohort studies[J]. Nutr, 2017, 16(1):26. |
|
|
|
2021, Vol. 27 
